(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of -0.39% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Azenta's revenue in 2025 is $633,800,000.On average, 3 Wall Street analysts forecast AZTA's revenue for 2025 to be $27,315,199,920, with the lowest AZTA revenue forecast at $27,170,397,951, and the highest AZTA revenue forecast at $27,417,151,860. On average, 3 Wall Street analysts forecast AZTA's revenue for 2026 to be $28,622,995,638, with the lowest AZTA revenue forecast at $27,852,519,146, and the highest AZTA revenue forecast at $29,019,449,970.
In 2027, AZTA is forecast to generate $30,592,448,915 in revenue, with the lowest revenue forecast at $30,592,448,915 and the highest revenue forecast at $30,592,448,915.